Xuetao Shi
3PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Jan 16, 2026
NALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial.Chuntao Gao, Yanqiao Zhang, Xiujuan Qu
|Apr 16, 2024
Neoadjuvant tislelizumab plus stereotactic body radiotherapy and adjuvant tislelizumab in early-stage resectable hepatocellular carcinoma: the Notable-HCC phase 1b trial.Zhongchao Li, Jing Liu, Bo Zhang
|Apr 11, 2020
Meloxicam, a Selective COX-2 Inhibitor, Mediates Hypoxia-Inducible Factor- (HIF-) 1α Signaling in Hepatocellular Carcinoma.Yinghong Zhou, Xiaofeng Dong, Peng Xiu
Pageof 1
Frequent Collaborators
2 joint publications
Pengfei Sun
2 joint publications
Jingtao Zhong
1 joint publications
Yinghong Zhou
1 joint publications
Xiaofeng Dong
1 joint publications
Peng Xiu
1 joint publications
Xin Wang
1 joint publications
Jianrong Yang
1 joint publications
Lei Li
1 joint publications
Zhongchao Li
1 joint publications
Zhongchao Li
